1. Home
  2. SPXX vs SOPH Comparison

SPXX vs SOPH Comparison

Compare SPXX & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPXX
  • SOPH
  • Stock Information
  • Founded
  • SPXX 2004
  • SOPH 2011
  • Country
  • SPXX United States
  • SOPH Switzerland
  • Employees
  • SPXX N/A
  • SOPH N/A
  • Industry
  • SPXX Trusts Except Educational Religious and Charitable
  • SOPH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SPXX Finance
  • SOPH Health Care
  • Exchange
  • SPXX Nasdaq
  • SOPH Nasdaq
  • Market Cap
  • SPXX 290.1M
  • SOPH 309.2M
  • IPO Year
  • SPXX N/A
  • SOPH 2021
  • Fundamental
  • Price
  • SPXX $16.32
  • SOPH $4.61
  • Analyst Decision
  • SPXX
  • SOPH Strong Buy
  • Analyst Count
  • SPXX 0
  • SOPH 3
  • Target Price
  • SPXX N/A
  • SOPH $7.33
  • AVG Volume (30 Days)
  • SPXX 51.3K
  • SOPH 70.7K
  • Earning Date
  • SPXX 01-01-0001
  • SOPH 08-06-2024
  • Dividend Yield
  • SPXX 7.55%
  • SOPH N/A
  • EPS Growth
  • SPXX N/A
  • SOPH N/A
  • EPS
  • SPXX N/A
  • SOPH N/A
  • Revenue
  • SPXX N/A
  • SOPH $64,184,000.00
  • Revenue This Year
  • SPXX N/A
  • SOPH $28.97
  • Revenue Next Year
  • SPXX N/A
  • SOPH $28.39
  • P/E Ratio
  • SPXX N/A
  • SOPH N/A
  • Revenue Growth
  • SPXX N/A
  • SOPH 26.68
  • 52 Week Low
  • SPXX $13.57
  • SOPH $2.13
  • 52 Week High
  • SPXX $16.05
  • SOPH $7.37
  • Technical
  • Relative Strength Index (RSI)
  • SPXX 60.75
  • SOPH 50.36
  • Support Level
  • SPXX $16.51
  • SOPH $4.48
  • Resistance Level
  • SPXX $16.70
  • SOPH $4.81
  • Average True Range (ATR)
  • SPXX 0.16
  • SOPH 0.20
  • MACD
  • SPXX -0.00
  • SOPH 0.02
  • Stochastic Oscillator
  • SPXX 70.77
  • SOPH 73.19

About SPXX Nuveen S&P 500 Dynamic Overwrite Fund

Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio (with a 55% long-term target) in an effort to enhance the Fund's risk-adjusted returns.

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Share on Social Networks: